18 - 75


Columbus, OH


Up to $2,200

NASH Trials in Columbus

Centricity Research is currently participating in the NASH NATiV3 study at our Columbus, Ohio location. NASH (Non-Alcoholic SteatoHepatitis) is the form of liver disease that is triggered by what has come to be known as the “Western diet”, characterized especially by high-fat, high-sugar, and processed foods. Among the effects of a prolonged Western diet is fat accumulation in liver cells (steatosis) which is described as Non-Alcoholic Fatty Liver Disease (NAFLD) and can predispose cells to injury.

Enroll Now


The primary objective of the NATiV3 clinical study is to evaluate the long-term effectiveness and safety of an investigational oral drug in the treatment of non-alcoholic steatohepatitis (NASH). You may be eligible to participate if you:

  • Are at least 18 years old
  • Cannot have known non-NASH liver diseases including:
    • Autoimmune diseases
    • Drug induced liver disease
    • Alcoholic liver disease
    • HIV
    • Active Hepatitis B or C

We now offer individuals with known risk factors of Non-Alcoholic Fatty Liver Disease (NAFLD) a free Fibroscan screening.

Ready to Volunteer?

Volunteer today to see if you qualify for our NASH NATiV3 clinical research study. Qualified volunteers may be compensated for time and travel.